SCHEMBL10677667

SCHEMBL10677667

CNc1c(C(=O)N(C)c2ccccc2)c(=O)n(C)c2ccccc12

nearest known ligand 0.71

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.71
▸ MEN1 O00255 4/20 0.71
▸ PGR P06401 1/20 0.71
▸ SRC P12931 3/20 0.62
▸ ALDH1A1 P00352 4/20 0.46
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ EGFR P00533 2/20 0.44
▸ KDM4E B2RXH2 4/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ HPGD P15428 2/20 0.42
▸ HTT P42858 1/20 0.42
▸ TP53 P04637 3/20 0.41
▸ LMNA P02545 2/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ NLRP3 Q96P20 1/20 0.41
▸ HDAC4 P56524 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10674517 0.88 MEN1 (0.68) KMT2AMEN1PGRSRCALDH1A1
SCHEMBL5166077 0.88 HDAC4 (0.56) KMT2AMEN1PGRSRCALDH1A1
SCHEMBL10671773 0.86 MEN1 (0.54) KMT2AMEN1PGRSRCTP53
SCHEMBL9200433 0.84 MEN1 (0.55) KMT2AMEN1PGRSRCALDH1A1
SCHEMBL10671530 0.84 MEN1 (0.55) KMT2AMEN1PGRSRCALDH1A1
SCHEMBL5165239 0.83 MEN1 (0.56) KMT2AMEN1PGRSRCALDH1A1
Roquinimex SCHEMBL42132 0.83 KMT2A (1.00) KMT2AMEN1PGRSRCALDH1A1
Roquinimex SCHEMBL8169579 0.83 KMT2A (1.00) KMT2AMEN1PGRSRCALDH1A1
Roquinimex SCHEMBL29359144 0.83 KMT2A (1.00) KMT2AMEN1PGRSRCALDH1A1
SCHEMBL10677325 0.82 MEN1 (0.49) KMT2AMEN1PGRSRCALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4738971-A ENHANCED CELL-MEDIATED IMMUNITY; ANTIARTHRITIC AGENTS; NONTOXIC AKTIEBOLASET LEO (SE) 1988-04-19 — — US disclosed
US-4547511-A FOR ENHANCIN CELL-MEDIATED IMMUNITY AKTIEBOLAGET LEO (SE) 1985-10-15 — — US disclosed
EP-0059698-B1 HETEROCYCLIC CARBOXAMIDES, COMPOSITIONS CONTAINING SUCH COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND METHODS OF TREATMENT THEREWITH AB LEO (SE) 1985-09-25 — — EP disclosed
EP-0059698-A1 Heterocyclic carboxamides, compositions containing such compounds, processes for their preparation and methods of treatment therewith AB LEO (SE) 1982-09-08 — — EP disclosed
Send feedback